Evaluation of the in vitro and in vivo genotoxicity of magnolia bark extract

Regulatory Toxicology and Pharmacology

Volumn 49, Issue 3, 2007, Pages 154-159

  Li, Ning ^a   Song, Yan ^a   Zhang, Wenzhong ^a   Wang, Wei ^a   Chen, Junshi ^a   Wong, Andrea W ^b   Roberts, Ashley ^b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Cantox Health Sciences International   (Canada)

Author keywords

Ames assay; Genotoxicity; Magnolia bark extract; MBE; Micronuclei; Micronucleus test; Mutagenicity; Safety

Indexed keywords

HONOKIOL; MAGNOLIA OFFICINALIS EXTRACT; MAGNOLOL; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL MUTATION; BACTERIAL REVERSE MUTATION ASSAY; BARK; CELL MATURATION; CHINESE MEDICINE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIET SUPPLEMENTATION; DRUG SAFETY; ERYTHROCYTE LIFESPAN; ESCHERICHIA COLI; FEMALE; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; JAPANESE MEDICINE; MAGNOLIACEAE; MALE; METABOLIC REGULATION; MICRONUCLEUS TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERTANT; SALMONELLA TYPHIMURIUM; TOXICITY TESTING;

ADMINISTRATION, ORAL; ANIMALS; BIPHENYL COMPOUNDS; BONE MARROW CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; FEMALE; LIGNANS; MAGNOLIA; MALE; MICE; MICE, INBRED STRAINS; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; MUTATION; PLANT BARK; PLANT EXTRACTS; REPRODUCIBILITY OF RESULTS; SALMONELLA TYPHIMURIUM;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MAGNOLIA; MUS; SALMONELLA TYPHIMURIUM;

EID: 36048931699     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2007.06.005     Document Type: Article

References (33)

1. Ames B.N., McCann J., and Yamasaki E. Methods for detecting carcinogens with the Salmonella/mammalian microsome mutagenicity test. Mutat. Res. 31 (1975) 347-364
2. Bang K.H., Kim Y.K., Min B.S., Na M.K., Rhee Y.H., Lee J.P., and Bae K.H. Antifungal activity of magnolol and honokiol. Arch. Pharm. Res. 23 (2000) 46-49
3. In: Chang H.-M., and But P.P.-H. (Eds). Houpo Magnolia officinalis. Pharmacology and Applications of Chinese Materia-Medica Vol. 2 (1986), Wiley, Philadelphia 878-880
4. Fujita S., and Taira J. Biphenyl compounds are hydroxyl radical scavengers: their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102. Free Radic. Biol. Med. 17 (1994) 273-277
5. Fujita M., Itokawa H., and Sashida Y. Honokiol, a new phenolic compound isolated from the bark of Magnolia obobvata Thunb. Chem. Pharm. Bull. 20 (1972) 212-213
6. Garrison R., and Chambliss W.G. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial. Altern. Ther. Health Med. 12 (2006) 50-54
7. Gee P., Maron D.M., and Ames B.N. Detection and classification of mutagens: a set of base-specific {{{ Salmonella}}} tester strains. Proc. Natl. Acad. Sci. USA 91 24 (1994) 11606-11610
8. + reversion in Escherichia coli. Mutat. Res. 38 (1976) 3-32
9. Hattori M., Endo Y., Takebe S., Kobashi K., Fukasaku N., and Namba T. Metabolism of magnolol from magnoliae cortex. II. Absorption, metabolism and excretion of [ring-(14)C]magnolol in rats. Chem. Pharm. Bull. 34 (1986) 158-167
10. Hisinaga A., Itoh T., Hasegawa Y., Emore K., Kita T., Okabe A., and Kurachi M. A case of sleep choking syndrome improved by the Kampo extract of Hange-koboku-to. Psychiatry Clin. Neurosci. 56 (2002) 237-325
11. Hsieh M.T., Chueh F.Y., and Lin M.T. Magnolol decreases body temperature by reducing 5-hydroxytryptamine release in the rat hypothalamus. Clin. Exp. Pharmacol. Physiol. 25 (1998) 813-817
12. Ikeda K., and Nagase H. Magnolol has the ability to induce apoptosis in tumor cells. Biol. Pharm. Bull. 25 (2002) 1546-1549
13. Ikeda K., Sakai Y., and Nagase H. Inhibitory effect of magnolol on tumour metastasis in mice. Phytother. Res. 17 (2003) 933-937
14. Iwasaki K., Cyong J.-C., Kitada S., Kitamura H., Ozeki J.-I., Satoh Y., Suzuki T., and Sasaki H. A traditional Chinese herbal medicine, banxia houpo tang, improves cough reflex of patients with aspiration pneumonia. J. Am. Geriatr. Soc. 50 (2002) 1751-1752
15. Konoshima T., Kozuka M., Tokuda H., Nishino H., Iwashima A., Haruna M., Ito K., and Tanabe M. Studies on inhibitors of skin tumor promotion, IX. Neolignans from Magnolia officinalis. J. Nat. Prod. 54 (1991) 816-822
16. Mantani N., Hisanaga A., Kogure T., Kita T., Shimada Y., and Terasawa K. Four cases of panic disorder successfully treated with Kampo (Japanese herbal) medicines: Kami-shoyo-san and Hange-koboku-to. Psychiatry Clin. Neurosci. 56 (2002) 617-620
17. Maron D.M., and Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113 (1983) 173-215
18. Maruyama Y., Kuribara H., Morita M., Yuzurihara M., and Weintraub S.T. Identification of magnolol and honokiol as anxiolytic agents in extracts of Saiboku-To, an oriental herbal medicine. J. Nat. Prod. 61 (1998) 135-138
19. Mortelmans K., Haworth S., Lawlor T., Speck W., Tainer B., and Zeiger E. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ. Mutagen. 8 Suppl. 7 (1986) 1-119
20. Mucci M., Carraro C., Mancino P., Monti M., Papdia L.S., Volpinin G., and Benvenuti C. Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium. Controlled clinical study in menopause. Minerva Ginecol. 58 (2006) 323-334
21. Nagase H., Ikeda K., and Sakai Y. Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. Invasiveness in vitro. Planta Med. 67 (2001) 705-708
22. Odagiri Y., Uchida H., and Shibazaki S. Interindividual variation in cytogenetic response to x-ray and colchicine measured with the cytokinesis-block micronucleus assay. Mutat. Res. 381 (1997) 1-13
23. st July, 1997.
24. Ogata M., Hoshi M., Shimotohno K., Urano S., and Endo T. Antioxidant activity of magnolol, honokiol, and related phenolic compounds. J. Am. Oil Chem. Soc. 74 (1997) 557-562
25. Oikawa T., Ito G., Koyama H., and Hanawa T. Prokinetic effect of a Kampo medicien, Hange-koboku-to (Banxia-houpo-tang), on patients with functional dyspepsia. Phytomedicine 12 (2005) 730-734
26. Saito J., Sakai Y., and Nagase H. In vitro anti-mutagenic effect of magnolol against direct and indirect mutagens. Mutat. Res. 609 (2006) 68-73
27. Sarker S.D. Biological activity of magnolol: a review. Fitoterapia 68 (1997) 3-8
28. Tsai T.T., and Chen C.F. Identification and determination of honokiol and magnolol from Magnolia officinalis by high-performance liquid chromatography with photodiode-array UV detection. J. Chromatogr. 598 (1992) 143-169
29. Tsai T.H., Chou C.J., and Chen C.F. Glucuronidation of magnolol assessed using HPLC/fluorescence. Planta Med. 61 (1995) 491-492
30. U.S. FDA, 2000. Bacterial reverse mutation test, in: Redbook 2000: Toxicological Principles for the Safety Assessment of Food Ingredients. U.S. Food and Drug Administration (U.S. FDA), Center for Food Safety and Nutrition (CFSAN), College Park, MD, available from: http://www.cfsan.fda.gov/∼redbook/redivc1a.html.
31. Yang H.-Y., and Chen C.-F. Subacute toxicity of 15 commonly used Chinese drugs (II). Yao Wu Shi Pin Fen Xi 5 (1997) 355-379
32. Yang H.-Y., and Chen C.-F. Pharmacology and toxicology of herbal medicine: Subacute toxicity of commonly used Chinese drugs. J. Toxicol. Sci. 23 Suppl. 2 (1998) 229-233
33. Zhao Z., Tang X.H.U.M., and Sashida Y. Pharmacognostical studies on the Magnolia bark (3). Determination of magnolol and honokiol in "Hou po"(cortex magnoliae) prepared from the bark of different age. Shoyakugaku Zasshi 45 (1991) 145-147